05:07 PM EDT, 08/25/2025 (MT Newswires) -- Johannes Jacob Pieter Kastelein, Director, Chief Scientific Officer, on August 21, 2025, sold 100,000 shares in NewAmsterdam Pharma ( NAMS ) for $2,471,640. Following the Form 4 filing with the SEC, Kastelein has control over a total of 69,302 ordinary shares of the company, with 69,302 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1936258/000095017025111241/xslF345X05/ownership.xml